<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108192-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Circuit Formation by Spatio-Temporal Control of Messenger RNA Translation</narrative>
   <narrative xml:lang="FR">Formation de circuits par contr&#xF4;le spatio-temporel de la traduction de l&apos;ARN messager</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The connections inside the brain need to be wired in a precise manner during development to ensure its proper function. This project will provide insight into circuit formation to help us understand how axon regeneration can improve clinical outcomes. Brain wiring, damage, and developmental defects Researchers have suggested that improper wiring of the nervous system is the basis for some neurodevelopmental defects. What are the mechanisms that guarantee the proper wiring between the billions of neurons during brain development? Molecules in the extracellular environment, called guidance cues, guide axons to their targets. These cues can be attractive, pulling axons in the right direction, or repulsive, which means they prevent axons from navigating to incorrect targets. Other conditions in which axons need to navigate in adults include regeneration after mechanical or degenerative stimuli, such as a spinal cord injury. Proper regeneration in adults is still a significant clinical problem. Project objectives This research project aims to: -generate a comprehensive picture of the molecular mechanisms underlying the nervous system&apos;s wiring -identify novel strategies to promote the proper guidance and wiring of the nervous system -further develop the graduate training environment and international research collaboration among the partners This work will shed new light on the mechanisms that govern the wiring of the nervous system and their role in axon regeneration. It could help to identify novel strategies to promote proper guidance and wiring in the neural circuits of abnormally developing axons, or damaged and regenerating axons. Project leadership The project lead is Fre&#xBF;de&#xBF;ric Charron at l&apos;Institut de recherches cliniques de Montre&#xBF;al, Universite&#xBF; de Montre&#xBF;al, Canada. His collaborators are Avraham Yaron, Weizmann Institute of Science, Israel, and Felipe A. Court, Universidad de Chile. Project funding This project is funded through the first research competition of the Joint Canada-Israel Health Research Initiative. The Initiative is a collaboration between the Azrieli Foundation, the Canadian Institutes of Health Research, the Israel Science Foundation, and Canada&apos;s International Development Research Centre.</narrative>
   <narrative xml:lang="FR">&#xC0; l&apos;int&#xE9;rieur du cerveau, les connexions doivent &#xEA;tre branch&#xE9;es de mani&#xE8;re pr&#xE9;cise durant le d&#xE9;veloppement pour assurer son bon fonctionnement. Ce projet permettra de mieux saisir la formation des circuits pour nous aider &#xE0; comprendre comment la r&#xE9;g&#xE9;n&#xE9;ration de l&apos;axone peut am&#xE9;liorer les r&#xE9;sultats cliniques.

C&#xE2;blage du cerveau, dommages et troubles du d&#xE9;veloppement

Des chercheurs ont laiss&#xE9; entendre que le mauvais c&#xE2;blage du syst&#xE8;me nerveux est le fondement de certains troubles du d&#xE9;veloppement neural. Quels sont les m&#xE9;canismes qui garantissent un bon c&#xE2;blage entre les milliards de neurones durant le d&#xE9;veloppement du cerveau? 

Des mol&#xE9;cules dans l&apos;environnement extracellulaire, appel&#xE9;es signaux de guidage, guident les axones vers leurs cibles. Ces signaux peuvent fonctionner par attraction, tirant les axones dans la bonne direction, ou par r&#xE9;pulsion, ce qui signifie qu&apos;ils emp&#xEA;chent les axones de s&apos;orienter vers des cibles incorrectes. Parmi les autres conditions dans lesquelles les axones doivent naviguer chez l&apos;adulte, mentionnons la r&#xE9;g&#xE9;n&#xE9;ration &#xE0; la suite de stimuli m&#xE9;caniques ou d&#xE9;g&#xE9;n&#xE9;ratifs, tels qu&apos;un traumatisme de la moelle &#xE9;pini&#xE8;re. Une r&#xE9;g&#xE9;n&#xE9;ration ad&#xE9;quate chez les adultes demeure un probl&#xE8;me clinique d&apos;importance. 

Objectifs du projet

Les vis&#xE9;es du projet sont les suivantes :

-d&#xE9;gager un portrait complet des m&#xE9;canismes mol&#xE9;culaires qui sous-tendent le c&#xE2;blage du syst&#xE8;me nerveux 

-d&#xE9;terminer des strat&#xE9;gies novatrices pour favoriser une orientation et un c&#xE2;blage ad&#xE9;quats du syst&#xE8;me nerveux

-am&#xE9;liorer davantage le cadre de la formation aux cycles sup&#xE9;rieurs et la collaboration internationale en mati&#xE8;re de recherche entre les partenaires

Ce travail jettera un nouvel &#xE9;clairage sur les m&#xE9;canismes qui r&#xE9;gissent le c&#xE2;blage du syst&#xE8;me nerveux et sur leur r&#xF4;le dans la r&#xE9;g&#xE9;n&#xE9;ration des axones. Il pourrait aider &#xE0; cerner des strat&#xE9;gies novatrices pour favoriser une orientation et un c&#xE2;blage ad&#xE9;quats des circuits neuraux des axones dont le d&#xE9;veloppement est anormal, ou des axones endommag&#xE9;s ou en r&#xE9;g&#xE9;n&#xE9;ration.

Direction du projet

Le projet est dirig&#xE9; par Fre&#xBF;de&#xBF;ric Charron, de l&apos;Institut de recherches cliniques de Montre&#xBF;al, &#xE0; l&apos;Universite&#xBF; de Montre&#xBF;al, au Canada. Ses collaborateurs sont Avraham Yaron, du Weizmann Institute of Science, en Isra&#xEB;l, et Felipe A. Court, de l&apos;Universidad de Chile, au Chili.
 
Financement du projet

Ce projet est financ&#xE9; par l&apos;entremise du premier concours de recherche du Programme conjoint canado-isra&#xE9;lien de recherche en sant&#xE9;. Le programme est une collaboration entre la Fondation Azrieli, les Instituts canadiens de recherche en sant&#xE9;, l&apos;Israel Science Foundation et le Centre de recherches pour le d&#xE9;veloppement international, organisme canadien.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Azrieli Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="2" type="24">
   <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
  </participating-org>
  <participating-org role="4" type="24">
   <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2015-12-01" type="2"></activity-date>
  <activity-date iso-date="2019-03-20" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-12-08"></transaction-date>
   <value currency="CAD" value-date="2015-12-08">166666</value>
   <provider-org>
    <narrative xml:lang="EN">Azrieli Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-12-31"></transaction-date>
   <value currency="CAD" value-date="2015-12-31">27777.8</value>
   <provider-org>
    <narrative xml:lang="EN">Azrieli Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-12-08"></transaction-date>
   <value currency="CAD" value-date="2015-12-08">480359</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-12-31"></transaction-date>
   <value currency="CAD" value-date="2015-12-31">80060.2</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-06-21"></transaction-date>
   <value currency="CAD" value-date="2016-06-21">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-06-21"></transaction-date>
   <value currency="CAD" value-date="2016-06-21">80059</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-12-01"></transaction-date>
   <value currency="CAD" value-date="2016-12-01">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-12-01"></transaction-date>
   <value currency="CAD" value-date="2016-12-01">80060</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-07-06"></transaction-date>
   <value currency="CAD" value-date="2017-07-06">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-07-06"></transaction-date>
   <value currency="CAD" value-date="2017-07-06">80059</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-01"></transaction-date>
   <value currency="CAD" value-date="2017-12-01">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-01"></transaction-date>
   <value currency="CAD" value-date="2017-12-01">80060</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-06-01"></transaction-date>
   <value currency="CAD" value-date="2018-06-01">19444</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-06-01"></transaction-date>
   <value currency="CAD" value-date="2018-06-01">56042</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-03-07"></transaction-date>
   <value currency="CAD" value-date="2019-03-07">24017</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-03-07"></transaction-date>
   <value currency="CAD" value-date="2019-03-07">8332</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-166666</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-480359</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">166666</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">480359</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
